These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 6442501
21. [Extraction of the exotoxin of anthrax vaccinal strain STI-1]. Lesniak OT, Saltykov RA. Zh Mikrobiol Epidemiol Immunobiol; 1974 Feb; (2):110-3. PubMed ID: 4218021 [No Abstract] [Full Text] [Related]
22. Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs. Ivins BE, Fellows PF, Nelson GO. Vaccine; 1994 Aug; 12(10):872-4. PubMed ID: 7975827 [Abstract] [Full Text] [Related]
23. [Extraction and study of anthrax protective antigen. III. Improvement in the method of obtaining chemical anthrax vaccine under laboratory conditions]. Debrin MI, Kuz'mich MK, Garin NS, Tarumov VS, Mikhaĭlov VV. Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):63-7. PubMed ID: 404807 [No Abstract] [Full Text] [Related]
24. Enhanced Immune Response to DNA Vaccine Encoding Bacillus anthracis PA-D4 Protects Mice against Anthrax Spore Challenge. Kim NY, Chang DS, Kim Y, Kim CH, Hur GH, Yang JM, Shin S. PLoS One; 2015 Feb; 10(10):e0139671. PubMed ID: 26430894 [Abstract] [Full Text] [Related]
25. Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine. Marcus H, Danieli R, Epstein E, Velan B, Shafferman A, Reuveny S. Infect Immun; 2004 Jun; 72(6):3471-7. PubMed ID: 15155654 [Abstract] [Full Text] [Related]
26. Progress and novel strategies in vaccine development and treatment of anthrax. Chitlaru T, Altboum Z, Reuveny S, Shafferman A. Immunol Rev; 2011 Jan; 239(1):221-36. PubMed ID: 21198675 [Abstract] [Full Text] [Related]
27. A heat-inducible Bacillus subtilis bacteriophage phi 105 expression system for the production of the protective antigen of Bacillus anthracis. Baillie LW, Moore P, McBride BW. FEMS Microbiol Lett; 1998 Jun 01; 163(1):43-7. PubMed ID: 9631544 [Abstract] [Full Text] [Related]
28. Development of an improved vaccine for anthrax. Leppla SH, Robbins JB, Schneerson R, Shiloach J. J Clin Invest; 2002 Jul 01; 110(2):141-4. PubMed ID: 12122102 [No Abstract] [Full Text] [Related]
29. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits. Lee DY, Chun JH, Ha HJ, Park J, Kim BS, Oh HB, Rhie GE. FEMS Immunol Med Microbiol; 2009 Nov 01; 57(2):165-72. PubMed ID: 19732139 [Abstract] [Full Text] [Related]
30. Next-Generation Bacillus anthracis Live Attenuated Spore Vaccine Based on the htrA(-) (High Temperature Requirement A) Sterne Strain. Chitlaru T, Israeli M, Bar-Haim E, Elia U, Rotem S, Ehrlich S, Cohen O, Shafferman A. Sci Rep; 2016 Jan 06; 6():18908. PubMed ID: 26732659 [Abstract] [Full Text] [Related]
31. Anthrax vaccine. Model of a response to the biologic warfare threat. Nass M. Infect Dis Clin North Am; 1999 Mar 06; 13(1):187-208, viii. PubMed ID: 10198799 [Abstract] [Full Text] [Related]
32. Passive transfer of protection against Bacillus anthracis infection in a murine model. Beedham RJ, Turnbull PC, Williamson ED. Vaccine; 2001 Aug 14; 19(31):4409-16. PubMed ID: 11483266 [Abstract] [Full Text] [Related]
33. Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions. Koehler SM, Buyuk F, Celebi O, Demiraslan H, Doganay M, Sahin M, Moehring J, Ndumnego OC, Otlu S, van Heerden H, Beyer W. BMC Vet Res; 2017 Jul 12; 13(1):220. PubMed ID: 28701192 [Abstract] [Full Text] [Related]
34. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions. Cote CK, Rossi CA, Kang AS, Morrow PR, Lee JS, Welkos SL. Microb Pathog; 2005 Jul 12; 38(5-6):209-25. PubMed ID: 15925272 [Abstract] [Full Text] [Related]
35. BclA and toxin antigens augment each other to protect NMRI mice from lethal Bacillus anthracis challenge. Köhler SM, Baillie LW, Beyer W. Vaccine; 2015 Jun 04; 33(24):2771-7. PubMed ID: 25917676 [Abstract] [Full Text] [Related]
37. Anthrax. Biological and immunological principles of diagnosis and prevention. 4. The dynamics and intensity of skin tests with anthraxin in guinea pigs inoculated with a STI vaccine. Shlyakhov EN. J Hyg Epidemiol Microbiol Immunol; 1970 Jan 01; 14(4):464-8. PubMed ID: 4992904 [No Abstract] [Full Text] [Related]
38. [Purification of a protective anthrax preparation]. Vylchev V, Syromashkova M, Mircheva I. Zh Mikrobiol Epidemiol Immunobiol; 1976 Apr 01; (3):53-6. PubMed ID: 822659 [Abstract] [Full Text] [Related]
39. [Immunobiological properties of 100 years old Bacillus anthracis vaccine strains Lange]. Sheremet'eva IuV, Gosmanov RG, Salmakov KM, Gosmanov NR. Zh Mikrobiol Epidemiol Immunobiol; 2004 Apr 01; (2):87-8. PubMed ID: 15188571 [Abstract] [Full Text] [Related]
40. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model. Peterson JW, Comer JE, Baze WB, Noffsinger DM, Wenglikowski A, Walberg KG, Hardcastle J, Pawlik J, Bush K, Taormina J, Moen S, Thomas J, Chatuev BM, Sower L, Chopra AK, Stanberry LR, Sawada R, Scholz WW, Sircar J. Infect Immun; 2007 Jul 01; 75(7):3414-24. PubMed ID: 17452469 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]